The presence of Claudin 5 in the BBB poses a significant challenge for drug delivery to the brain. Its role in maintaining the barrier restricts the passage of many therapeutic agents. However, understanding the mechanisms of Claudin 5 can aid in developing strategies to transiently modulate the BBB, allowing for more effective delivery of drugs to the brain.